dc.contributor | Universidade Estadual Paulista (UNESP) | |
dc.creator | Minicucci, Marcos Ferreira | |
dc.creator | Gaiolla, Paula Schmidt Azevedo | |
dc.creator | Polegato, Bertha Furlan | |
dc.creator | Paiva, Sergio A.R. | |
dc.creator | Zornoff, Leonardo Antonio Mamede | |
dc.date | 2014-05-27T11:27:25Z | |
dc.date | 2016-10-25T18:40:36Z | |
dc.date | 2014-05-27T11:27:25Z | |
dc.date | 2016-10-25T18:40:36Z | |
dc.date | 2012-12-04 | |
dc.date.accessioned | 2017-04-06T02:06:02Z | |
dc.date.available | 2017-04-06T02:06:02Z | |
dc.identifier | Inflammation and Allergy - Drug Targets, v. 11, n. 6, p. 442-447, 2012. | |
dc.identifier | 1871-5281 | |
dc.identifier | http://hdl.handle.net/11449/74048 | |
dc.identifier | http://acervodigital.unesp.br/handle/11449/74048 | |
dc.identifier | 10.2174/187152812803589958 | |
dc.identifier | 2-s2.0-84870257839 | |
dc.identifier | http://dx.doi.org/10.2174/187152812803589958 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/894823 | |
dc.description | Cardiac or ventricular remodeling is characterized by molecular, cellular, and interstitial alterations that lead to changes in heart size, mass, geometry and function in response to a given insult. Currently, tobacco smoke exposure is recognized as one of these insults. Indeed, tobacco smoke exposure induces the enlargement of the left-sided cardiac chambers, myocardial hypertrophy, and ventricular dysfunction. Potential mechanisms for these alterations include hemodynamic and neurohormonal changes, oxidative stress, inflammation, nitric oxide bioavailability, matrix metalloproteinases and mitogen-activated protein kinase activation. This review will focus on the concepts, relevance, and potential mechanisms of cardiac remodeling induced by tobacco smoke. © 2012 Bentham Science Publishers. | |
dc.language | eng | |
dc.relation | Inflammation and Allergy - Drug Targets | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Matrix metalloproteinases | |
dc.subject | Oxidative stress | |
dc.subject | Tobacco smoke exposure | |
dc.subject | Ventricular remodeling | |
dc.subject | acetylcysteine | |
dc.subject | adenosine triphosphate | |
dc.subject | beta carotene | |
dc.subject | calcium channel L type | |
dc.subject | calcium ion | |
dc.subject | gamma interferon | |
dc.subject | gelatinase B | |
dc.subject | interleukin 1 | |
dc.subject | interleukin 18 | |
dc.subject | interleukin 6 | |
dc.subject | mitogen activated protein kinase | |
dc.subject | neurohormone | |
dc.subject | nicotine | |
dc.subject | nitric oxide | |
dc.subject | reactive oxygen metabolite | |
dc.subject | taurine | |
dc.subject | tobacco smoke | |
dc.subject | tumor necrosis factor alpha | |
dc.subject | vitamin D | |
dc.subject | calcium mobilization | |
dc.subject | cytokine production | |
dc.subject | energy metabolism | |
dc.subject | exposure | |
dc.subject | heart disease | |
dc.subject | heart infarction | |
dc.subject | heart muscle contractility | |
dc.subject | heart size | |
dc.subject | heart ventricle failure | |
dc.subject | heart ventricle hypertrophy | |
dc.subject | heart ventricle remodeling | |
dc.subject | hemodynamic stress | |
dc.subject | hypoxemia | |
dc.subject | inflammation | |
dc.subject | nonhuman | |
dc.subject | oxidative stress | |
dc.subject | renin angiotensin aldosterone system | |
dc.subject | smoking | |
dc.subject | supplementation | |
dc.subject | Animals | |
dc.subject | Humans | |
dc.subject | Inflammation | |
dc.subject | Matrix Metalloproteinases | |
dc.subject | Mitogen-Activated Protein Kinases | |
dc.subject | Nitric Oxide | |
dc.subject | Oxidative Stress | |
dc.subject | Smoking | |
dc.subject | Ventricular Dysfunction, Left | |
dc.subject | Ventricular Remodeling | |
dc.title | Cardiac remodeling induced by smoking: Concepts, relevance, and potential mechanisms | |
dc.type | Otro | |